ArticleCancer biology & therapy2022

BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes.

Li Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.